LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | CGP60474 | 1.11 | uM | LJP6 | 72 | hr | 1097 | 538 | 3769 | 0.1427 | -0.2093 |
Hs 578T | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 658 | 540 | 3846 | 0.1405 | -0.0370 |
BT-20 | AZD 5438 | 10.0 | uM | LJP6 | 72 | hr | 1097 | 540 | 3769 | 0.1433 | -0.2085 |
BT-20 | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 540 | 3769 | 0.1433 | -0.2085 |
MDA-MB-231 | Geldanamycin | 10.0 | uM | LJP5 | 72 | hr | 1235 | 541 | 4513 | 0.1200 | -0.2118 |
MDA-MB-231 | JNK-9L | 10.0 | uM | LJP6 | 72 | hr | 1235 | 541 | 4513 | 0.1200 | -0.2118 |
Hs 578T | SNS-032 | 0.12 | uM | LJP6 | 72 | hr | 658 | 542 | 3846 | 0.1411 | -0.0362 |
Hs 578T | SNS-032 | 1.11 | uM | LJP6 | 72 | hr | 658 | 548 | 3846 | 0.1425 | -0.0346 |
MCF 10A | Mitoxantrone | 10.0 | uM | LJP6 | 72 | hr | 962 | 552 | 10605 | 0.0521 | -0.0425 |
MDA-MB-231 | WZ-4-145 | 10.0 | uM | LJP6 | 72 | hr | 1235 | 552 | 4513 | 0.1224 | -0.2086 |
MDA-MB-231 | SNS-032 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 554 | 4513 | 0.1227 | -0.2081 |
Hs 578T | Torin2 | 1.11 | uM | LJP5 | 72 | hr | 658 | 554 | 3846 | 0.1440 | -0.0327 |
Hs 578T | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 658 | 556 | 3846 | 0.1447 | -0.0320 |
SK-BR-3 | LDN-193189 | 10.0 | uM | LJP5 | 72 | hr | 1401 | 557 | 4223 | 0.1319 | -0.2993 |
Hs 578T | Momelotinib | 10.0 | uM | LJP5 | 72 | hr | 658 | 561 | 3846 | 0.1459 | -0.0305 |
Hs 578T | AZD 5438 | 1.11 | uM | LJP6 | 72 | hr | 658 | 562 | 3846 | 0.1462 | -0.0301 |
MDA-MB-231 | AZD8055 | 10.0 | uM | LJP6 | 72 | hr | 1235 | 562 | 4513 | 0.1246 | -0.2055 |
MCF7 | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 566 | 4093 | 0.1384 | -0.2231 |
Hs 578T | PF477736 | 3.33 | uM | LJP5 | 72 | hr | 658 | 566 | 3846 | 0.1473 | -0.0288 |
BT-20 | Withaferin A | 10.0 | uM | LJP6 | 72 | hr | 1097 | 566 | 3769 | 0.1502 | -0.1987 |
Hs 578T | Y39983 | 10.0 | uM | LJP6 | 72 | hr | 658 | 567 | 3846 | 0.1476 | -0.0284 |
Hs 578T | Dasatinib | 1.11 | uM | LJP5 | 72 | hr | 658 | 567 | 3846 | 0.1475 | -0.0285 |
Hs 578T | Neratinib | 10.0 | uM | LJP5 | 72 | hr | 658 | 568 | 3846 | 0.1479 | -0.0281 |
BT-20 | Withaferin A | 3.33 | uM | LJP5 | 72 | hr | 1097 | 568 | 3769 | 0.1509 | -0.1978 |
MCF7 | CGP60474 | 10.0 | uM | LJP5 | 72 | hr | 1209 | 568 | 4093 | 0.1389 | -0.2224 |